Home > Drug Search >
  • company_query: Beijing Minhai Biotechnology
  •   > 
Drug Filter
Category:
chemistry (6) biology (39)
Status:
Approved (4) Phase Ⅲ (12) Phase Ⅱ (21) Phase Ⅰ (8)
Clinical Stage:
Pending (4) Active (32) Discontinued (5)
Bio-Type:
Gene therapy (4) CAR T cell therapy (4) Vaccine (25) Blood extraction (1) Other recombinant protein (1) Whole antibody (1) Fusion protein (3)
Indication:
Meningitis (2) Acute coronary syndrome (ACS) (2) Acute lymphoblastic leukaemia (ALL) (2) Angina pectoris (1) Atrial fibrillation (1) Chronic lymphocytic leukemia (CLL) (1) Cognitive disorders (1) Crohn's disease (1) Delayed graft function (1) Avian influenza (1) Cutaneous T cell lymphoma (CTCL) (1) Cholera (1) HBV infection (3) Influenza virus infection (4) Hepatitis A viral infection (2) Rabies (2) Leukemia (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pneumonia (2) Diphtheria (1) Haemophilus infection (1) Pertussis (1) Prostate cancer (1) Tetanus (2) Botulism (1) Schizophrenia (1) Seasonal allergic rhinitis (1) Rotavirus infection (1) Ulcerative colitis (1) Adrenoleucodystrophy (1) Head and neck cancer (1) Colorectal cancer (1) Yersinia pestis infection (1) Neuroblastoma (1) Stroke (2) Sickle cell disease (1) Neutropenia (1) Renal carcinoma (1) Autoimmune diseases (1) Alcoholism (1) Smallpox infection (1) Mesothelioma (1) Dengue fever (1) Thelassemia (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top